These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 37994185)
1. Prediction of duloxetine efficacy in addition to self-management in painful temporomandibular disorders: A randomised, placebo-controlled clinical trial. Ferreira DMAO; Soares FFC; Raimundini AA; Bonjardim LR; Costa YM; Conti PCR J Oral Rehabil; 2024 Mar; 51(3):476-486. PubMed ID: 37994185 [TBL] [Abstract][Full Text] [Related]
2. The effect of duloxetine on mechanistic pain profiles, cognitive factors and clinical pain in patients with painful knee osteoarthritis-A randomized, double-blind, placebo-controlled, crossover study. Petersen KK; Drewes AM; Olesen AE; Ammitzbøll N; Bertoli D; Brock C; Arendt-Nielsen L Eur J Pain; 2022 Sep; 26(8):1650-1664. PubMed ID: 35638317 [TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients. Murakami M; Osada K; Mizuno H; Ochiai T; Alev L; Nishioka K Arthritis Res Ther; 2015 Aug; 17(1):224. PubMed ID: 26296539 [TBL] [Abstract][Full Text] [Related]
4. Duloxetine 60 mg once-daily in the treatment of painful physical symptoms in patients with major depressive disorder. Brannan SK; Mallinckrodt CH; Brown EB; Wohlreich MM; Watkin JG; Schatzberg AF J Psychiatr Res; 2005 Jan; 39(1):43-53. PubMed ID: 15504423 [TBL] [Abstract][Full Text] [Related]
5. Conditioned pain modulation predicts duloxetine efficacy in painful diabetic neuropathy. Yarnitsky D; Granot M; Nahman-Averbuch H; Khamaisi M; Granovsky Y Pain; 2012 Jun; 153(6):1193-1198. PubMed ID: 22480803 [TBL] [Abstract][Full Text] [Related]
6. A randomized placebo-controlled trial of duloxetine in patients with major depressive disorder and associated painful physical symptoms. Gaynor PJ; Gopal M; Zheng W; Martinez JM; Robinson MJ; Marangell LB Curr Med Res Opin; 2011 Oct; 27(10):1849-58. PubMed ID: 21838411 [TBL] [Abstract][Full Text] [Related]
7. Treatment of patients with diabetic peripheral neuropathic pain in China: a double-blind randomised trial of duloxetine vs. placebo. Gao Y; Guo X; Han P; Li Q; Yang G; Qu S; Yue L; Wang CN; Skljarevski V; Dueñas H; Raskin J; Gu L Int J Clin Pract; 2015 Sep; 69(9):957-66. PubMed ID: 25939897 [TBL] [Abstract][Full Text] [Related]
9. Influence of psychometric and sleep quality features on painful mechanical sensitivity and pain modulation in patients with temporomandibular disorders. Salbego RS; Conti PCR; Soares FFC; Ferreira DMAO; Herreira-Ferreira M; de Lima-Netto BA; Svensson P; Costa YM; Bonjardim LR Clin Oral Investig; 2024 May; 28(6):302. PubMed ID: 38714576 [TBL] [Abstract][Full Text] [Related]
10. Individualization of Migraine Prevention: A Randomized Controlled Trial of Psychophysical-based Prediction of Duloxetine Efficacy. Kisler LB; Weissman-Fogel I; Coghill RC; Sprecher E; Yarnitsky D; Granovsky Y Clin J Pain; 2019 Sep; 35(9):753-765. PubMed ID: 31241488 [TBL] [Abstract][Full Text] [Related]
11. Study protocol for a multi-institutional, randomised, double-blinded, placebo-controlled phase III trial investigating additive efficacy of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: the DIRECT study. Matsuoka H; Ishiki H; Iwase S; Koyama A; Kawaguchi T; Kizawa Y; Morita T; Matsuda Y; Miyaji T; Ariyoshi K; Yamaguchi T BMJ Open; 2017 Aug; 7(8):e017280. PubMed ID: 28851798 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Duloxetine in Patients with Central Post-stroke Pain: A Randomized Double Blind Placebo Controlled Trial. Mahesh B; Singh VK; Pathak A; Kumar A; Mishra VN; Joshi D; Chaurasia RN Pain Med; 2023 Jun; 24(6):610-617. PubMed ID: 36409018 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of duloxetine in Chinese patients with chronic pain due to osteoarthritis: a randomized, double-blind, placebo-controlled study. Wang G; Bi L; Li X; Li Z; Zhao D; Chen J; He D; Wang CN; Dueñas H; Skljarevski V; Yue L Osteoarthritis Cartilage; 2017 Jun; 25(6):832-838. PubMed ID: 28043937 [TBL] [Abstract][Full Text] [Related]
15. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601. Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL; Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828 [TBL] [Abstract][Full Text] [Related]
17. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. Detke MJ; Lu Y; Goldstein DJ; Hayes JR; Demitrack MA J Clin Psychiatry; 2002 Apr; 63(4):308-15. PubMed ID: 12000204 [TBL] [Abstract][Full Text] [Related]
18. A mechanism-based proof of concept study on the effects of duloxetine in patients with painful knee osteoarthritis. Ammitzbøll N; Arendt-Nielsen L; Bertoli D; Brock C; Olesen AE; Kappel A; Drewes AM; Petersen KK Trials; 2021 Dec; 22(1):958. PubMed ID: 34961547 [TBL] [Abstract][Full Text] [Related]
19. Duloxetine: a review of its use in the treatment of generalized anxiety disorder. Carter NJ; McCormack PL CNS Drugs; 2009; 23(6):523-41. PubMed ID: 19480470 [TBL] [Abstract][Full Text] [Related]
20. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. Matsuoka H; Clark K; Fazekas B; Oyamada S; Brown L; Ishiki H; Matsuda Y; Hasuo H; Ariyoshi K; Lee J; Le B; Allcroft P; Kochovska S; Fujiwara N; Miyaji T; Lovell M; Agar M; Yamaguchi T; Satomi E; Iwase S; Phillips J; Koyama A; Currow DC BMJ Open; 2022 Feb; 12(2):e050182. PubMed ID: 35131817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]